Trial · NCT03928145
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 18 of 18
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Mean change from baseline in 24-h systolic blood pressure measured by ABPM. | 12 weeks | Difference between the treatment arms in mean change from baseline in 24-h systolic blood pressure measured by ABPM. |
| Primary | Mean change from baseline in 24-h diastolic blood pressure measured by ABPM. | 12 weeks | Difference between the treatment arms in mean change from baseline in 24-h diastolic blood pressure measured by ABPM. |
| Secondary | Mean change from baseline in daytime and nighttime blood pressure measured by ABPM. | 12 weeks | Difference between the treatment arms in mean change from baseline in daytime and nighttime systolic and diastolic blood pressure measured by ABPM. |
| Secondary | Mean change from baseline in systolic and diastolic blood pressure measured by office blood pressure. | 12 weeks | Difference between the treatment arms in mean change from baseline in systolic and diastolic blood pressure measured by office blood pressure. |
| Secondary | Proportion of participants reporting adverse events. | 12 weeks | Difference between treatment arms in the proportion of participants reporting adverse events. |
| Secondary | Mean change from baseline in total cholesterol. | 12 weeks | Difference between the treatment arms in mean change from baseline in serum total cholesterol, measured in mg/dL. |
| Secondary | Mean change from baseline in HDL cholesterol (HDL-C). | 12 weeks | Difference between the treatment arms in mean change from baseline in serum HDL cholesterol (HDL-C), measured in mg/dL. |
| Secondary | Mean change from baseline in LDL cholesterol (LDL-C). | 12 weeks | Difference between the treatment arms in mean change from baseline in serum LDL cholesterol (LDL-C), measured in mg/dL. |
| Secondary | Mean change from baseline in triglycerides. | 12 weeks | Difference between the treatment arms in mean change from baseline in serum triglycerides, measured in mg/dL. |
| Secondary | Mean change from baseline in creatinine. | 12 weeks | Difference between the treatment arms in mean change from baseline in serum creatinine, measured in mg/dL. |
| Secondary | Mean change from baseline in urea. | 12 weeks | Difference between the treatment arms in mean change from baseline in serum urea, measured in mg/dL. |
| Secondary | Mean change from baseline in potassium. | 12 weeks | Difference between the treatment arms in mean change from baseline in serum potassium, measured in mEq/L. |
| Secondary | Mean change from baseline in sodium. | 12 weeks | Difference between the treatment arms in mean change from baseline in serum sodium, measured in mg/dL. |
| Secondary | Mean change from baseline in magnesium. | 12 weeks | Difference between the treatment arms in mean change from baseline in serum magnesium, measured in mg/dL. |
| Secondary | Mean change from baseline in uric acid. | 12 weeks | Difference between the treatment arms in mean change from baseline in serum uric acid, measured in mg/dL. |
| Secondary | Mean change from baseline in fasting plasma glucose. | 12 weeks | Difference between the treatment arms in mean change from baseline in fasting plasma glucose, measured in mg/dL. |
| Secondary | Mean change from baseline in hemoglobin A1c (HbA1c). | 12 weeks | Difference between the treatment arms in mean change from baseline in hemoglobin A1c (HbA1c), measured in percentage. |
| Secondary | Proportion of participants achieving blood pressure control. | 12 weeks. | Difference between treatment arms in the proportion of participants achieving blood pressure control. Blood pressure control will be defined as \<140/90 mmHg and \<130/80 mmHg for office BP and 24-h ABPM, respectively. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03928145/registered